Pablo Lara

451 total citations
11 papers, 334 citations indexed

About

Pablo Lara is a scholar working on Molecular Biology, Immunology and Biomedical Engineering. According to data from OpenAlex, Pablo Lara has authored 11 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Immunology and 4 papers in Biomedical Engineering. Recurrent topics in Pablo Lara's work include Extracellular vesicles in disease (7 papers), Nanoparticle-Based Drug Delivery (3 papers) and Immune cells in cancer (3 papers). Pablo Lara is often cited by papers focused on Extracellular vesicles in disease (7 papers), Nanoparticle-Based Drug Delivery (3 papers) and Immune cells in cancer (3 papers). Pablo Lara collaborates with scholars based in Netherlands, Chile and Brazil. Pablo Lara's co-authors include Marcelo J. Kogan, Luis J. Cruz, Andrew F. G. Quest, Simón Guerrero, Alan Chan, Felipe Oyarzún-Ampuero, Lisette Leyton, Ferry Ossendorp, Edison Salas‐Huenuleo and Areli Cárdenas and has published in prestigious journals such as Nanoscale, Molecules and Biomedicine & Pharmacotherapy.

In The Last Decade

Pablo Lara

10 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pablo Lara Netherlands 9 210 104 89 57 49 11 334
Chunxian Piao South Korea 15 270 1.3× 94 0.9× 62 0.7× 72 1.3× 62 1.3× 19 478
Mohammad Sameer Khan India 11 185 0.9× 121 1.2× 67 0.8× 121 2.1× 36 0.7× 17 442
Maha Ali Alghamdi Saudi Arabia 10 308 1.5× 102 1.0× 111 1.2× 80 1.4× 35 0.7× 25 558
Yuxi Zhang China 11 181 0.9× 61 0.6× 34 0.4× 39 0.7× 35 0.7× 19 357
Qingqing Huang China 12 162 0.8× 101 1.0× 39 0.4× 83 1.5× 33 0.7× 32 347
Faraz Zarghami Iran 6 184 0.9× 65 0.6× 44 0.5× 90 1.6× 18 0.4× 7 349
Yoon Young Kang South Korea 12 344 1.6× 87 0.8× 111 1.2× 55 1.0× 115 2.3× 21 495
Jingwen Huang China 9 191 0.9× 107 1.0× 81 0.9× 100 1.8× 53 1.1× 18 427
Nikhil Rai India 11 149 0.7× 117 1.1× 33 0.4× 122 2.1× 42 0.9× 21 359
Kave Moloudi South Africa 12 101 0.5× 169 1.6× 38 0.4× 118 2.1× 26 0.5× 21 384

Countries citing papers authored by Pablo Lara

Since Specialization
Citations

This map shows the geographic impact of Pablo Lara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Lara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Lara more than expected).

Fields of papers citing papers by Pablo Lara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo Lara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Lara. The network helps show where Pablo Lara may publish in the future.

Co-authorship network of co-authors of Pablo Lara

This figure shows the co-authorship network connecting the top 25 collaborators of Pablo Lara. A scholar is included among the top collaborators of Pablo Lara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pablo Lara. Pablo Lara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Carvalho, Thaís Gomes de, Pablo Lara, Cícero Flávio Soares Aragão, et al.. (2023). Inhibition of murine colorectal cancer metastasis by targeting M2-TAM through STAT3/NF-kB/AKT signaling using macrophage 1-derived extracellular vesicles loaded with oxaliplatin, retinoic acid, and Libidibia ferrea. Biomedicine & Pharmacotherapy. 168. 115663–115663. 26 indexed citations
4.
Lara, Pablo, et al.. (2022). M1-derived extracellular vesicles enhance photodynamic therapy and promote immunological memory in preclinical models of colon cancer. Journal of Nanobiotechnology. 20(1). 252–252. 22 indexed citations
6.
Lara, Pablo, Edison Salas‐Huenuleo, Iva Polakovičová, et al.. (2020). Gold nanoparticle based double-labeling of melanoma extracellular vesicles to determine the specificity of uptake by cells and preferential accumulation in small metastatic lung tumors. Journal of Nanobiotechnology. 18(1). 20–20. 87 indexed citations
7.
Lara, Pablo, Alan Chan, Luis J. Cruz, Andrew F. G. Quest, & Marcelo J. Kogan. (2020). Exploiting the Natural Properties of Extracellular Vesicles in Targeted Delivery towards Specific Cells and Tissues. Pharmaceutics. 12(11). 1022–1022. 44 indexed citations
8.
Lara, Pablo, Simón Guerrero, Edison Salas‐Huenuleo, et al.. (2018). Encapsulation of Gold Nanostructures and Oil-in-Water Nanocarriers in Microgels with Biomedical Potential. Molecules. 23(5). 1208–1208. 17 indexed citations
9.
Guerrero, Simón, Pablo Lara, Fanny Guzmán, et al.. (2018). Gold Nanoparticles As Tracking Devices to Shed Light on the Role of Caveolin-1 in Early Stages of Melanoma Metastasis. Nanomedicine. 13(12). 1447–1462. 8 indexed citations
10.
Guerrero, Simón, Pablo Lara, Areli Cárdenas, et al.. (2018). Curcumin-loaded nanoemulsion: a new safe and effective formulation to prevent tumor reincidence and metastasis. Nanoscale. 10(47). 22612–22622. 72 indexed citations
11.
Hassan, Natalia, Felipe Oyarzún-Ampuero, Pablo Lara, et al.. (2014). Flow Chemistry to Control the Synthesis of Nano and Microparticles for Biomedical Applications. Current Topics in Medicinal Chemistry. 14(5). 676–689. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026